. 2019 Oct 16;4(5):e00376-19. doi: 10.1128/mSphere.00376-19

TABLE 1.

Microbiological data and plasmid characterization of two OXA-58-producing Acinetobacter species clinical isolates recovered in Brazil^a

Strain	Species	Yr of Isolation	Clinical specimen	MLST	MIC (μg/ml)												Plasmid	Size (bp)	ORF	G+C (%)	AbGR	Genetic marker(s)
Strain	Species	Yr of Isolation	Clinical specimen	MLST	CAZ	CRO	FEP	IPM	MEM	AMK	GEN	CIP	TIG	MIN	PMB	SUT	Plasmid	Size (bp)	ORF	G+C (%)	AbGR	Resistance	Virulence
Asp-1069	A. seifertii	1993	Tracheal aspirate	ST551	256	128	128	32	32	256	512	1	0.5	0.25	4	>32	pAs1069_a	24,672	44	36.62	GR8	aphA6, bla_OXA-58	map
Asp-1069	A. seifertii	1993	Tracheal aspirate	ST551	256	128	128	32	32	256	512	1	0.5	0.25	4	>32	pAs1069_b	13,129	14	35.65	NT		ppa

Acb-45063	A. baumannii	2010	Blood	ST15	256	512	64	32	16	8	512	64	1	0.25	0.06	>32	pAb45063_a	183,767	209	37.61	NT	strA, strB, sul2	sulP, glmM
Acb-45063	A. baumannii	2010	Blood	ST15	256	512	64	32	16	8	512	64	1	0.25	0.06	>32	pAb45063_b	19,808	24	38.51	GR4	aac(3)-IIa, bla_TEM-1B, bla_OXA-58	tonB, sep

MLST, multilocus sequence typing; CAZ, ceftazidime; CRO, ceftriaxone; FEP, cefepime; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; TIG, tigecycline; MIN, minocycline; PMB, polymyxin B; SUT, trimethoprim-sulfamethoxazole; ORF, open reading frame; G+C, guanine-cytosine content; AbGR, Acinetobacter replicon type group; NT, nontypeable.